Varex Imaging Corporation

NasdaqGS:VREX Voorraadrapport

Marktkapitalisatie: US$433.7m

Varex Imaging Toekomstige groei

Future criteriumcontroles 3/6

Varex Imaging zal naar verwachting groeien in winst en omzet met respectievelijk 128% en 3.4% per jaar. De winst per aandeel zal naar verwachting groeien met 128.3% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.6% zijn.

Belangrijke informatie

128.0%

Groei van de winst

128.31%

Groei van de winst per aandeel

Medical Equipment winstgroei16.4%
Inkomstengroei3.4%
Toekomstig rendement op eigen vermogen9.56%
Dekking van analisten

Low

Laatst bijgewerkt05 Jun 2026

Recente toekomstige groei-updates

Analyseartikel Aug 10

Varex Imaging Corporation (NASDAQ:VREX) Just Reported Earnings, And Analysts Cut Their Target Price

NasdaqGS:VREX 1 Year Share Price vs Fair Value Explore Varex Imaging's Fair Values from the Community and select yours...

Recent updates

Narratiefupdate Jun 17

VREX: Higher Long Term P/E Assumption Will Drive Future Repricing

The analyst price target for Varex Imaging has moved slightly lower to $18.0 from $18.4, with analysts citing updates in discount rate, revenue growth, profit margin and future P/E assumptions as key drivers of the change. What’s in the News for Varex Imaging Varex Imaging issued earnings guidance for the third quarter of fiscal 2026, with expected revenues in the range of $210 million to $225 million.
Narratiefupdate Jun 02

VREX: Future Upside Will Rely On Executing 2026 Revenue Guidance

Analysts have kept their $16.00 price target for Varex Imaging unchanged, citing updated assumptions that now reflect a slightly lower discount rate, a modest adjustment to expected revenue growth and profit margins, and a higher future P/E multiple. What's in the News Varex Imaging issued earnings guidance for the third quarter of fiscal 2026, with expected revenue in the range of $210 million to $225 million.
Narratiefupdate May 12

VREX: Future Upside Will Depend On Discount Rate And Margin Delivery

Analysts have raised their price target on Varex Imaging from $16.00 to $18.00, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E levels. Analyst Commentary Even with the price target moving to US$18.00, some bearish analysts are stressing that this is not an all clear signal for Varex Imaging.
Narratiefupdate Apr 27

VREX: Future Upside Will Depend On Q2 2026 Revenue And Margin Delivery

Analysts recently raised their price target on Varex Imaging by $2. This change reflects updated views on revenue growth, profit margin potential, and a lower assumed future P/E multiple, while keeping fair value estimates unchanged.
Narratiefupdate Apr 10

VREX: Refined Discount Rate And P/E Assumptions Will Support Future Repricing

Analysts recently raised their price target on Varex Imaging by $2, reflecting updated assumptions on discount rate, profit margin, and future P/E. They see these assumptions as better aligned with the company’s risk and earnings profile.
Narratiefupdate Mar 26

VREX: Higher Profitability Assumptions Will Support A Repriced Earnings Multiple

Analysts have raised their average price target for Varex Imaging by $1, reflecting updated views on fair value, profitability assumptions, and P/E expectations cited in recent research, including the latest move from B. Riley.
Narratiefupdate Mar 12

VREX: Future Returns Will Hinge On Executing Q2 2026 Revenue Guidance

Narrative Update on Varex Imaging Analysts have lifted their price target on Varex Imaging by $2, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E that support a refreshed view of the company’s valuation profile. Analyst Commentary Even with the updated price target, some bearish analysts remain cautious.
Narratiefupdate Feb 25

VREX: Future Returns Will Depend On Delivering Q2 2026 Guidance Execution

Analysts have lifted their price target on Varex Imaging to $16.0 from $14.5, citing updated assumptions around fair value, discount rate, revenue, profit margin and future P/E following recent research that included a $2 increase in target price at B. Riley.
Narratiefupdate Feb 11

VREX: Future Returns Will Balance Q4 Beat Against Ongoing Execution Risks

Analysts have revised their fair value estimate for Varex Imaging to $14.50 from $12.00, citing updated assumptions on the discount rate, revenue growth, profit margins and future P/E. This follows recent research that included a lower Street price target of $18 from $23, after Q4 revenue of $229M came in above prior estimates and guidance.
Analyseartikel Feb 05

It Looks Like Varex Imaging Corporation's (NASDAQ:VREX) CEO May Expect Their Salary To Be Put Under The Microscope

Key Insights Varex Imaging to hold its Annual General Meeting on 12th of February Total pay for CEO Sunny Sanyal...
Narratiefupdate Jan 27

VREX: Future Returns Will Reflect Cautious Stance After Lowered Price Outlook

Narrative Update Analysts have trimmed their price target on Varex Imaging by $5 to $18, citing recent Q4 revenue of $229M coming in above their estimates and within guidance, along with Q1 2026 revenue guidance of $200M to $215M that aligns closely with current expectations. Analyst Commentary Bearish analysts are reacting to the recent update by trimming their expectations, even as the latest numbers line up with prior guidance and estimates.
Narratiefupdate Jan 10

VREX: Future Returns Will Reflect Trimmed Outlook After Q1 2026 Revenue Guidance

Narrative Update on Varex Imaging The analyst consensus price target for Varex Imaging has shifted to US$18 from US$23, with analysts pointing to the recent Q4 revenue outcome of US$229m versus prior expectations and the Q1 2026 guidance range of US$200m to US$215m as key inputs behind the revision. Analyst Commentary Bearish analysts have responded to the latest results and guidance by trimming their expectations, even though the recent Q4 revenue outcome of US$229m sat at the high end of management's US$210m to US$230m range and ahead of prior estimates.
Analyseartikel Jan 09

Is Varex Imaging (NASDAQ:VREX) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Narratiefupdate Dec 14

VREX: Future Performance Will Reflect Trimmed Outlook Amid Solid Recent Results

Analysts have trimmed their price target on Varex Imaging to $18 from $23, citing slightly softer long term growth assumptions, despite recent quarterly revenues and forward guidance coming in ahead of or in line with prior expectations. Analyst Commentary Bearish analysts acknowledge Varex Imaging's better than expected quarterly performance and solid positioning within its end markets, but remain cautious on the durability of growth and the balance of risk and reward at current levels.
Analyseartikel Nov 20

Varex Imaging Corporation (NASDAQ:VREX) Shares Could Be 35% Below Their Intrinsic Value Estimate

Key Insights Varex Imaging's estimated fair value is US$15.84 based on 2 Stage Free Cash Flow to Equity Varex Imaging's...
Analyseartikel Aug 10

Varex Imaging Corporation (NASDAQ:VREX) Just Reported Earnings, And Analysts Cut Their Target Price

NasdaqGS:VREX 1 Year Share Price vs Fair Value Explore Varex Imaging's Fair Values from the Community and select yours...
Analyseartikel Aug 06

The Returns At Varex Imaging (NASDAQ:VREX) Aren't Growing

NasdaqGS:VREX 1 Year Share Price vs Fair Value Explore Varex Imaging's Fair Values from the Community and select yours...
Analyseartikel Jul 19

Calculating The Intrinsic Value Of Varex Imaging Corporation (NASDAQ:VREX)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Varex Imaging fair value estimate is US$8.72 With US$7.24...
Analyseartikel Jun 10

These 4 Measures Indicate That Varex Imaging (NASDAQ:VREX) Is Using Debt Extensively

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Analyseartikel May 11

Earnings Beat: Varex Imaging Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Varex Imaging Corporation ( NASDAQ:VREX ) just released its quarterly report and things are looking bullish. The...
Analyseartikel Apr 25

Lacklustre Performance Is Driving Varex Imaging Corporation's (NASDAQ:VREX) 32% Price Drop

To the annoyance of some shareholders, Varex Imaging Corporation ( NASDAQ:VREX ) shares are down a considerable 32% in...
Analyseartikel Apr 25

Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Revenues As Shares Take 32% Pounding

To the annoyance of some shareholders, Varex Imaging Corporation ( NASDAQ:VREX ) shares are down a considerable 32% in...
Analyseartikel Apr 04

Be Wary Of Varex Imaging (NASDAQ:VREX) And Its Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
Seeking Alpha Jan 21

Varex Imaging Corporation: A Mixed Picture

Summary Varex Imaging Corporation's stock has declined 25% over the past year, and revenues decreased year-over-year basis in the most recent quarter. The stock did see net insider buying in its stock in 2024 and Varex did deliver solid operating cash flow in its last quarterly earnings report. What is ahead for Varex and its shareholders in 2025? An updated analysis of Varex Imaging Corporation follows in the paragraphs below. Read the full article on Seeking Alpha
Analyseartikel Dec 19

Varex Imaging (NASDAQ:VREX) Is Finding It Tricky To Allocate Its Capital

If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When we...
Analyseartikel Nov 07

There's Reason For Concern Over Varex Imaging Corporation's (NASDAQ:VREX) Massive 29% Price Jump

The Varex Imaging Corporation ( NASDAQ:VREX ) share price has done very well over the last month, posting an excellent...
Analyseartikel Oct 22

Does Varex Imaging (NASDAQ:VREX) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
User avatar
Nieuw narratief Sep 24

Expanding In India And Innovating In Photon Technology Boosts Prospects Despite Challenges In China And Semiconductor Softness

Expansion into India and focus on photon counting technology aim to recover market share in radiographic and dental sectors, potentially increasing revenue.
Seeking Alpha Sep 11

Varex Imaging: Headroom Capped Without Higher Earnings On Capital Employed

Summary Varex Imaging has high net working capital density and low capital turnover that see it earn sub-par rates on its operating assets. Varex's Q3 FY24 earnings showed extended weakness across all operating domains, with China a continued drag on performance. Valuations are unsupportive and without capacity to roll back cash earnings to grow the capital base or earnings power, my view is VREX is worth ~$13/share today. Read the full article on Seeking Alpha
Analyseartikel Aug 20

Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Earnings

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 18x, you may...
Analyseartikel May 10

We Like Varex Imaging's (NASDAQ:VREX) Earnings For More Than Just Statutory Profit

Despite posting healthy earnings, Varex Imaging Corporation's ( NASDAQ:VREX ) stock has been quite weak. Along with the...
Seeking Alpha Feb 07

Varex Imaging Corporation: The Picture Is Cloudy After Quarterly Results

Summary Today, we look at Varex Imaging Corporation, which just posted Q1 2024 results, with non-GAAP earnings of six cents a share, falling short of expectations. The company is facing several near-term headwinds, but profit and sales growth are projected to return in FY2025. An analysis around Varex Imaging Corporation is presented in the paragraphs below. Read the full article on Seeking Alpha
Analyseartikel Dec 14

We Like These Underlying Return On Capital Trends At Varex Imaging (NASDAQ:VREX)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Winst- en omzetgroeiprognoses

NasdaqGS:VREX - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
9/30/20289264231511
9/30/20279053034555
9/30/20268711081385
4/3/2026858-83-31-2N/A
1/2/2026854-68-1316N/A
10/3/2025845-701942N/A
7/4/2025821-1323660N/A
4/4/2025828-433860N/A
1/3/2025821-492647N/A
9/27/2024811-492047N/A
6/28/2024833344269N/A
3/29/2024856427298N/A
12/29/20238784597122N/A
9/29/20238934788108N/A
6/30/2023897295378N/A
3/31/2023880291338N/A
12/30/202286632-202N/A
9/30/202285930-417N/A
7/1/2022854263650N/A
4/1/2022851306075N/A
12/31/2021840258296N/A
10/1/2021818177893N/A
7/2/2021762-181430N/A
4/2/2021722-58-89N/A
1/1/2021715-63-22-3N/A
10/2/2020738-58-1013N/A
7/3/2020771-232248N/A
4/3/202079643763N/A
1/3/202079511N/A75N/A
9/27/201978116N/A72N/A
6/28/20197837N/A68N/A
3/29/201977813N/A73N/A
12/28/201878319N/A65N/A
9/28/201877328N/A85N/A
6/29/201878442N/A82N/A
3/30/201876349N/A87N/A
12/29/201771752N/A96N/A
9/29/201769852N/A75N/A
6/30/201765559N/A80N/A
3/31/201763666N/A80N/A
12/30/201663166N/A87N/A
9/30/201662069N/A74N/A
7/1/201660862N/A85N/A
10/2/201563280N/A85N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er wordt voorspeld dat VREX de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 3.5% ).

Winst versus markt: Er wordt verwacht dat VREX de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.

Hoge groeiwinsten: Er wordt verwacht dat VREX binnen 3 jaar winstgevend zal worden.

Omzet versus markt: De omzet van VREX ( 3.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 12.6% per jaar).

Hoge groei-inkomsten: De omzet van VREX ( 3.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen VREX zal naar verwachting over 3 jaar laag zijn ( 9.6 %).


Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/06/29 22:22
Aandelenkoers aan het einde van de dag2026/06/29 00:00
Inkomsten2026/04/03
Jaarlijkse inkomsten2025/10/03

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Varex Imaging Corporation wordt gevolgd door 9 analisten. 5 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Anderson SchockB. Riley Securities, Inc.
Lawrence SolowCJS Securities, Inc.
Rajbir DenhoyJefferies LLC